The Net Margin of Alphamab Oncology (9966.HK) is 25.99%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 25.99% |
| 2023-12-31 | -96.26% |
| 2022-12-31 | -195.22% |
| 2021-12-31 | -282.44% |
| 2020-12-31 | -282.44% |